Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
56 participants
INTERVENTIONAL
2024-07-31
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Zinc Bioavailability From Amaranth-enriched Maize Tortillas
NCT02208609
Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months
NCT02208635
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala
NCT00098202
Effects of Iron and/or Zinc Supplementation in Mexican School Children Exposed to Lead
NCT02346188
Iron-Biofortified Beans Intervention in Mexico
NCT03835377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Biofortified maize
Children consume biofortified maize that has been traditionally bred to have higher amounts of iron and zinc. Children consume the biofortified maize via 10-15 tortillas a day for 3 days.
Biofortified maize
Maize that has been grown to have higher amounts of iron and zinc.
Traditional Maize
Children consume traditional maize that has lower amounts of iron and zinc compared to the biofortified maize. Children consume the maize via 10-15 tortillas a day for 3 days.
Placebo
Traditional maize
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biofortified maize
Maize that has been grown to have higher amounts of iron and zinc.
Placebo
Traditional maize
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between10-85%tile
* Typically eat homemade tortillas at each meal every day
Exclusion Criteria
* Hemoglobin less than 12.9 g/dl for children 10-11 yrs old and less than13.4 g/dl for children 12-14 yrs old (Per the WHO's 2024 publication hemoglobin cut-offs for identifying anemia are 5-11 yrs: less than 11.5 g/dl; 12-14 yrs: less than 12.0 g/dl. To adjust for the elevation of Tecpán at 2254 m, 1.4 g/dl is added to the cut-off point.)
* Girls who are having a menstrual period during the metabolic studies
10 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Nutrition of Central America and Panama
OTHER
Semilla Nueva
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy F Krebs, MD, MS
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Nutrition of Central America and Panama
Guatemala City, Departamento de Guatemala, Guatemala
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Manolo Mazariegos, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7200AA23FA00027
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
24-1030
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.